GLIOGENE is an international consortium of familial brain tumor researchers in the United States, the United Kingdom, Sweden, Denmark and Israel. With GLIOGENE, we may be able learn more about possible genes related to this disease -- and then identify a genetic link among family members of brain tumor patients. Identifying a genetic link may provide information about the disease -- information that one day we hope will lead to improved treatment, as well as preventive strategies.

GLIOGENE is the largest study ever to be conducted on familial gliomas, or primary brain tumors. Researchers aim to screen approximately 15,000 individuals worldwide during the five-year study. Find out more...

MD ANDERSON NEWS

  • Best therapies for relapsed diffuse large b-cell lymphoma
    Listen now: http://www3.mdanderson.org/streams/AudioPlayer.cfm?mediaID=33730EF8-3A53-4052-8976-438A0C0D00A7 When diffuse large b-cell lymphoma returns after the cancer patient is initially treated, it is called relapsed diffuse large b-cell lymphoma (DLBCL). If...
  • Immunotherapy: unleashing immune system to attack cancer
    Listen now: http://www3.mdanderson.org/streams/AudioPlayer.cfm?mediaID=41A3C0D7-451F-472B-977B-D6D2477C1E86 Cancer immunotherapy treats the immune system rather than the tumor. Jim Allison, Ph.D., professor in Immunology at MD Anderson Cancer Center, has developed...
  • Leukemia (AML/MDS) Moon Shots update
    Listen now: http://www3.mdanderson.org/streams/AudioPlayer.cfm?mediaID=4C790159-2E17-4C0F-894B-DC0A353FF8D1 Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce...